Cormorant Asset Management, LP Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$2.1T
Holdings
48
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (48 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | $513.0B | 24.50% | |
| 2 | AMAMAMBRX BIOPHARMA INC | 11,231,000 | $159.9B | 7.64% | |
| 3 | EYPTEYEPOINT PHARMACEUTICALS INC | 6,038,235 | $139.5B | 6.66% | |
| 4 | BBIOBRIDGEBIO PHARMA INC | 3,344,179 | $135.0B | 6.45% | |
| 5 | ACLXARCELLX INC | 1,700,000 | $94.3B | 4.51% | |
| 6 | —RAYZEBIO INC | 1,213,478 | $75.4B | 3.60% | |
| 7 | BMEABIOMEA FUSION INC | 3,570,872 | $51.8B | 2.48% | |
| 8 | IMVTIMMUNOVANT INC | 1,165,000 | $49.1B | 2.34% | |
| 9 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,550,000 | $48.6B | 2.32% | |
| 10 | PHVSPHARVARIS N V | 1,711,460 | $48.0B | 2.29% | |
| 11 | ALXOALX ONCOLOGY HLDGS INC | 3,142,079 | $46.8B | 2.23% | |
| 12 | TARSTARSUS PHARMACEUTICALS INC | 2,221,422 | $45.0B | 2.15% | |
| 13 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,800,000 | $42.5B | 2.03% | |
| 14 | PCVXVAXCYTE INC | 665,000 | $41.8B | 1.99% | |
| 15 | CRNXCRINETICS PHARMACEUTICALS IN | 1,150,000 | $40.9B | 1.95% | |
| 16 | APLSAPELLIS PHARMACEUTICALS INC | 625,000 | $37.4B | 1.79% | |
| 17 | MRNS*MARINUS PHARMACEUTICALS INC | 3,250,000 | $35.3B | 1.69% | |
| 18 | AUTLAUTOLUS THERAPEUTICS PLC | 5,450,000 | $35.1B | 1.68% | |
| 19 | OLMAOLEMA PHARMACEUTICALS INC | 2,456,800 | $34.5B | 1.65% | |
| 20 | IMRXIMMUNEERING CORP | 4,204,364 | $30.9B | 1.48% | |
| 21 | EWTXEDGEWISE THERAPEUTICS INC | 2,551,989 | $27.9B | 1.33% | |
| 22 | AVTEAEROVATE THERAPEUTICS INC | 1,211,696 | $27.4B | 1.31% | |
| 23 | CRGXCARGO THERAPEUTICS INC | 1,182,563 | $27.4B | 1.31% | |
| 24 | SNDXSYNDAX PHARMACEUTICALS INC | 1,175,000 | $25.4B | 1.21% | |
| 25 | KRROKORRO BIO INC | 529,170 | $25.4B | 1.21% | |
| 26 | RYTMRHYTHM PHARMACEUTICALS INC | 550,000 | $25.3B | 1.21% | |
| 27 | ABVXABIVAX SA | 2,130,000 | $22.8B | 1.09% | |
| 28 | HARPUSDHARPOON THERAPEUTICS INC | 2,349,060 | $22.6B | 1.08% | |
| 29 | SYRESPYRE THERAPEUTICS INC | 937,080 | $20.2B | 0.96% | |
| 30 | IM8NINSMED INC | 575,000 | $17.8B | 0.85% | |
| 31 | IDYAIDEAYA BIOSCIENCES INC | 450,000 | $16.0B | 0.76% | |
| 32 | AXNX*AXONICS INC | 250,000 | $15.6B | 0.74% | |
| 33 | NGNENEUROGENE INC | 746,180 | $14.5B | 0.69% | |
| 34 | —LONGBOARD PHARMACEUTICALS IN | 2,353,141 | $14.2B | 0.68% | |
| 35 | PRAXPRAXIS PRECISION MEDICINES I | 633,345 | $14.1B | 0.67% | |
| 36 | RCKTROCKET PHARMACEUTICALS INC | 450,000 | $13.5B | 0.64% | |
| 37 | RAPTEURRAPT THERAPEUTICS INC | 496,750 | $12.3B | 0.59% | |
| 38 | IRONDISC MEDICINE INC | 125,000 | $7.2B | 0.34% | |
| 39 | STOKSTOKE THERAPEUTICS INC | 1,087,807 | $5.7B | 0.27% | |
| 40 | EDITEDITAS MEDICINE INC | 500,000 | $5.1B | 0.24% | Put |
| 41 | VERVVERVE THERAPEUTICS INC | 350,000 | $4.9B | 0.23% | |
| 42 | LNTHLANTHEUS HLDGS INC | 75,000 | $4.7B | 0.22% | |
| 43 | CNTACENTESSA PHARMACEUTICALS PLC | 561,600 | $4.5B | 0.21% | |
| 44 | BHVNBIOHAVEN LTD | 81,963 | $3.5B | 0.17% | |
| 45 | GHRSGH RESEARCH PLC | 593,043 | $3.4B | 0.16% | |
| 46 | VYNEVYNE THERAPEUTICS INC | 1,394,336 | $3.2B | 0.16% | |
| 47 | BCABBIOATLA INC | 1,181,115 | $2.9B | 0.14% | |
| 48 | NMRANEUMORA THERAPEUTICS INC. | 92,293 | $1.6B | 0.08% |